Navigation Links
QinetiQ North America and NASA Advance Space Travel with First Forward Osmosis Experiments in Microgravity
Date:9/19/2011

MCLEAN, Va., Sept. 19, 2011 /PRNewswire/ -- QinetiQ North America announced today the results of another successful experiment completed on board the final flight of the space shuttle Atlantis (STS-135) in July 2011. The experiment, the first of its kind in microgravity, tested the novel application in space of a technology modeled on a biological process used by cells on Earth to recover water from their environment. Already engineered for use in applications ranging from desalination plants to treating non-potable water for backpackers, forward osmosis is the natural diffusion of water through a semi-permeable membrane. The membrane permits small polar molecules like water to pass through while blocking most other molecules like salts, sugars, starches, or proteins, and stopping all microorganisms like protozoan parasites, bacteria, and viruses. On earth, the process converts undrinkable water to a potable fluid in a few hours; how the process would work in reduced gravity was unknown prior to this experiment.

In testing on the shuttle, the experiment demonstrated the process to be nearly as effective in microgravity as in normal gravity. For the microgravity experiment, scientists from QinetiQ North America and NASA worked with the creators of the X-Pack™, a commercially available product, to develop the Forward Osmosis Bag (FOB), a passive, personal, portable water purification device. The experiment used a combination of indicator dyes and calculated the effect of mechanical mixing -- i.e., shaking three of the experiment's six FOBs for a few minutes -- on the rate of water passage across the membrane. Additional ground control experiments for the forward osmosis study will be conducted later this month at the Kennedy Space Center.

"If we discover that manual manipulation helps, then we hope a long-term application would result in a spacesuit which would induce the mechanical mixing as astronauts move around during spacewalks," said QinetiQ North America project engineer Monica Soler.

Soler added that, unlike reverse osmosis, which requires a significant amount of energy, forward osmosis provides an energy-efficient process that does not increase payload weight or energy needs of the spacecraft. QinetiQ North America developed and administered the forward osmosis experiment, as well as other scientific experiments, on board the final flight of Atlantis, as a part of its Engineering Services Contract (ESC) with NASA.

In the future, the Forward Osmosis Bag may be used for water recovery aboard the International Space Station or in contingency, return-to-earth scenarios where the crew requires emergency potable water. The process could also extend the reach of manned space travel and enable longer space walks by giving astronauts the ability to produce drinkable fluids in space.

About QinetiQ North America

QinetiQ North America (QNA) is a subsidiary of QinetiQ Group plc, the FTSE250 company listed on the London Stock Exchange (LSE: QQ.L).  Operating in North America, QNA delivers world-class technology, responsive services, and innovative solutions for global markets, focusing on US government and commercial customers.  Its engineers, scientists and other professionals deliver high quality products and services that leverage detailed mission knowledge and proven, reliable tools and methodologies to meet the rapidly changing demands of national defense, homeland security and information assurance customers. QNA is headquartered in McLean, Virginia. For more information visit www.qinetiq-na.com.

Contact:
Michael Rudd, Boscobel (for QinetiQ North America, Inc.)
301-588-2900
mrudd@boscobel.com


'/>"/>
SOURCE QinetiQ North America
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. QinetiQ North America Gains New Insights into Plant Growth and Sustainable Life Support on Final Shuttle Flight
2. NHS Northamptonshire Chief Executive John Parkes Accepts Visiting Professorship
3. BioSpace Spotlights Northern Californias Life Science Community
4. Perdue AgriBusiness and TCI Collaborate to Bring Profitable New Crop to North Carolina
5. ACT Obtains Exclusive License for Hemangioblast Technology in North America
6. Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in the US and Europe
7. Generex Announces U.S. Congressman Curt Weldon, Co-Founder of the Congressional Diabetes Caucus, to Champion Generex Initiatives in Asia and North America
8. Cord Blood America Enters Agreement With Regence, Serving BlueCross and BlueShield Programs in the Northwest U.S. and Mountain Regions
9. Northern Illinois University scientists find simple way to produce graphene
10. Dendreon CEO Dr. Mitchell Gold Named Ernst & Young Entrepreneur Of The Year® 2011 Pacific Northwest Award Winner
11. Northwest Biotherapeutics Announces Change and Expansion of Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
Breaking Biology Technology:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
Breaking Biology News(10 mins):